Elawyers Elawyers
Washington| Change

Lawson v. Praxair, Inc., 3:16-cv-2435-BRM-DEA. (2019)

Court: District Court, D. New Jersey Number: infdco20191218895 Visitors: 10
Filed: Dec. 12, 2019
Latest Update: Dec. 12, 2019
Summary: ORDER TO SEAL DOCUMENTS BRIAN R. MARTINOTTI , District Judge . AND NOW, upon consideration of the Praxair Defendants' Motion Redact Portions of the January 16, 2018 Hearing Transcript [D.E. 235], specifically lines 40:2-41:10 and 45:10-18, and good cause having been shown, this Court finds as follows: Findings of Fact 1. The January 16, 2018 Hearing Transcript [D.E. 235], specifically lines 40:2-41:10 and 45:10-18, contains proprietary, confidential, trade secret, and sensitive business
More

ORDER TO SEAL DOCUMENTS

AND NOW, upon consideration of the Praxair Defendants' Motion Redact Portions of the January 16, 2018 Hearing Transcript [D.E. 235], specifically lines 40:2-41:10 and 45:10-18, and good cause having been shown, this Court finds as follows:

Findings of Fact

1. The January 16, 2018 Hearing Transcript [D.E. 235], specifically lines 40:2-41:10 and 45:10-18, contains proprietary, confidential, trade secret, and sensitive business information, including confidential information related to Praxair's confidential testing procedures that are not known to the public.

2. The information therein concerns confidential testing procedures and processes and this information is not available to the public.

3. The Praxair Defendants have a legitimate interest in maintaining the confidentiality of the redacted portions of the January 16, 2018 Hearing Transcript [D.E. 235], specifically lines 40:2-41:10 and 45:10-18, because these very small segments of the transcript contain descriptions of Praxair's confidential testing procedures that are not known to the public or competitors.

4. The Praxair Defendants will suffer serious competitive disadvantage and injury if the business information contained in these materials is disclosed publicly.

Conclusions of Law

5. Because the January 16, 2018 Hearing Transcript [D.E. 235], specifically lines 40:2-41:10 and 45:10-18, contains proprietary, confidential, and trade secret information, concerning testing procedures, and because the Praxair Defendants would suffer serious competitive injury if such information was made publicly available, good cause exists to keep these materials under seal.

IT IS on this 11th day of December, 2019, hereby

ORDERED that the Praxair Defendants' Motion to Redact shall be, and hereby is GRANTED; and it is further

ORDERED that the January 16, 2018 Hearing Transcript [D.E. 235], specifically lines 40:2-41:10 and 45:10-18, shall be REDACTED.

Source:  Leagle

Can't find what you're looking for?

Post a free question on our public forum.
Ask a Question
Search for lawyers by practice areas.
Find a Lawyer